{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:56:38Z","timestamp":1778954198900,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11033-021-07097-z","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:05:27Z","timestamp":1642982727000},"page":"2839-2845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study"],"prefix":"10.1007","volume":"49","author":[{"given":"Elham","family":"Shakerian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Afarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasoul","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-8099","authenticated-orcid":false,"given":"Narges","family":"Mohammadtaghvaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"6","key":"7097_CR1","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655\u20131669","journal-title":"Gastroenterology"},{"issue":"8","key":"7097_CR2","doi-asserted-by":"publisher","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","volume":"305","author":"A Mallat","year":"2013","unstructured":"Mallat A, Lotersztajn S (2013) Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 305(8):C789\u2013C799","journal-title":"Am J Physiol Cell Physiol"},{"key":"7097_CR3","first-page":"24","volume":"27","author":"S Davison","year":"2018","unstructured":"Davison S (2018) Assessment of liver disease in cystic fibrosis. Paediatr Respir Rev 27:24\u201327","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"7097_CR4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","volume":"123","author":"D Schuppan","year":"2013","unstructured":"Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Investig 123(5):1887\u20131901","journal-title":"J Clin Investig"},{"issue":"5","key":"7097_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","volume":"37","author":"G Carpino","year":"2005","unstructured":"Carpino G, Morini S, Corradini SG, Franchitto A, Merli M, Siciliano M et al (2005) Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis 37(5):349\u2013356","journal-title":"Dig Liver Dis"},{"key":"7097_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.omtn.2017.11.010","volume":"10","author":"L Zhou","year":"2018","unstructured":"Zhou L, Liu S, Han M, Ma Y, Feng S, Zhao J et al (2018) miR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis. Mol Ther Nucleic Acids 10:91\u2013102","journal-title":"Mol Ther Nucleic Acids"},{"key":"7097_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1440-1746.2011.07002.x","volume":"27","author":"K Iwaisako","year":"2012","unstructured":"Iwaisako K, Brenner DA, Kisseleva T (2012) What\u2019s new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27:65\u201368","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"7097_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen Y-F, Clutinger CK, Tigno XT et al (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148(2):774\u2013781","journal-title":"Endocrinology"},{"issue":"4","key":"7097_CR9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3892\/ijo.2014.2552","volume":"45","author":"K Yoshida","year":"2014","unstructured":"Yoshida K, Murata M, Yamaguchi T, Matsuzaki K (2014) TGF-\u03b2\/Smad signaling during hepatic fibro-carcinogenesis. Int J Oncol 45(4):1363\u20131371","journal-title":"Int J Oncol"},{"issue":"1","key":"7097_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(03)00178-8","volume":"39","author":"Y-O Kweon","year":"2003","unstructured":"Kweon Y-O, Paik Y-H, Schnabl B, Qian T, Lemasters JJ, Brenner DA (2003) Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 39(1):38\u201346","journal-title":"J Hepatol"},{"issue":"2","key":"7097_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25(2):195\u2013206","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"7097_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11906-017-0730-5","volume":"19","author":"Z Huang","year":"2017","unstructured":"Huang Z, Xu A, Cheung BM (2017) The potential role of fibroblast growth factor 21 in lipid metabolism and hypertension. Curr Hypertens Rep 19(4):28","journal-title":"Curr Hypertens Rep"},{"key":"7097_CR13","unstructured":"Hertog M, Hollman P (1996) Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr"},{"issue":"5","key":"7097_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/molecules21050623","volume":"21","author":"J Mlcek","year":"2016","unstructured":"Mlcek J, Jurikova T, Skrovankova S, Sochor J (2016) Quercetin and its anti-allergic immune response. Molecules 21(5):623","journal-title":"Molecules"},{"issue":"2","key":"7097_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/eji.200425778","volume":"35","author":"M Comalada","year":"2005","unstructured":"Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, G\u00e1lvez J et al (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-\u03baB pathway. Eur J Immunol 35(2):584\u2013592","journal-title":"Eur J Immunol"},{"issue":"1","key":"7097_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.taap.2007.04.004","volume":"222","author":"AW Boots","year":"2007","unstructured":"Boots AW, Li H, Schins RP, Duffin R, Heemskerk JW, Bast A et al (2007) The quercetin paradox. Toxicol Appl Pharmacol 222(1):89\u201396","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"7097_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3835(01)00443-8","volume":"171","author":"K Igura","year":"2001","unstructured":"Igura K, Ohta T, Kuroda Y, Kaji K (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171(1):11\u201316","journal-title":"Cancer Lett"},{"issue":"5","key":"7097_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0168-8278(00)80305-0","volume":"33","author":"W Peres","year":"2000","unstructured":"Peres W, Tu\u00f1\u00f3n MJ, Collado PS, Herrmann S, Marroni N, Gonz\u00e1lez-Gallego J (2000) The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 33(5):742\u2013750","journal-title":"J Hepatol"},{"issue":"4","key":"7097_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1023\/A:1022869716643","volume":"48","author":"A Pavanato","year":"2003","unstructured":"Pavanato A, Tu\u00f1\u00f3n MJ, S\u00e1nchez-Campos S, Marroni CA, Llesuy S, Gonz\u00e1lez-Gallego J et al (2003) Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis. Dig Dis Sci 48(4):824\u2013829","journal-title":"Dig Dis Sci"},{"issue":"12","key":"7097_CR20","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1080\/13880209.2016.1223143","volume":"54","author":"L He","year":"2016","unstructured":"He L, Hou X, Fan F, Wu H (2016) Quercetin stimulates mitochondrial apoptosis dependent on activation of endoplasmic reticulum stress in hepatic stellate cells. Pharm Biol 54(12):3237\u20133243","journal-title":"Pharm Biol"},{"issue":"1","key":"7097_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.metabol.2012.06.008","volume":"62","author":"H Tsuchiya","year":"2013","unstructured":"Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, Shiota G (2013) High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 62(1):62\u201369","journal-title":"Metabolism"},{"key":"7097_CR22","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1111\/j.1440-1746.2006.04658.x","volume":"22","author":"T Kisseleva","year":"2007","unstructured":"Kisseleva T, Brenner DA (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22:S73\u2013S78","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"7097_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"A Gressner","year":"2006","unstructured":"Gressner A, Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets. J Cell Mol Med 10(1):76\u201399","journal-title":"J Cell Mol Med"},{"issue":"11","key":"7097_CR24","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3390\/cells9112456","volume":"9","author":"N Smith-Cortinez","year":"2020","unstructured":"Smith-Cortinez N, van Eunen K, Heegsma J, Serna-Salas SA, Sydor S, Bechmann LP et al (2020) Simultaneous induction of glycolysis and oxidative phosphorylation during activation of hepatic stellate cells reveals novel mitochondrial targets to treat liver fibrosis. Cells 9(11):2456","journal-title":"Cells"},{"issue":"8","key":"7097_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/j.1478-3231.2008.01825.x","volume":"28","author":"G Svegliati-Baroni","year":"2008","unstructured":"Svegliati-Baroni G, De Minicis S, Marzioni M (2008) Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 28(8):1052\u20131064","journal-title":"Liver Int"},{"issue":"2","key":"7097_CR26","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.jhepr.2020.100217","volume":"3","author":"EL Shepherd","year":"2021","unstructured":"Shepherd EL, Saborano R, Northall E, Matsuda K, Ogino H, Yashiro H et al (2021) Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis. JHEP Rep 3(2):100217","journal-title":"JHEP Rep"},{"issue":"22","key":"7097_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0973-1296.62900","volume":"6","author":"X Chen","year":"2010","unstructured":"Chen X (2010) Protective effects of quercetin on liver injury induced by ethanol. Pharmacogn Mag 6(22):135","journal-title":"Pharmacogn Mag"},{"key":"7097_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7243\/2055-091X-4-7","volume":"4","author":"S Gedikli","year":"2017","unstructured":"Gedikli S, Ozkanlar S, Gur C, Sengul E, Gelen V (2017) Preventive effects of quercetin on liver damages in highfat diet-induced obesity. J Histol Histopathol 4:7","journal-title":"J Histol Histopathol"},{"issue":"3\u20134","key":"7097_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1039\/c0fo00158a","volume":"2","author":"L-C Wu","year":"2011","unstructured":"Wu L-C, Lu I-W, Chung C-F, Wu H-Y, Liu Y-T (2011) Antiproliferative mechanisms of quercetin in rat activated hepatic stellate cells. Food Funct 2(3\u20134):204\u2013212","journal-title":"Food Funct"},{"issue":"12","key":"7097_CR30","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/j.1440-1746.2012.07262.x","volume":"27","author":"LD Hern\u00e1ndez-Ortega","year":"2012","unstructured":"Hern\u00e1ndez-Ortega LD, Alc\u00e1ntar-D\u00edaz BE, Ruiz-Corro LA, Sandoval-Rodriguez A, Bueno-Topete M, Armendariz-Borunda J et al (2012) Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic\/anti-fibrogenic molecules balance. J Gastroenterol Hepatol 27(12):1865\u20131872","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-07097-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07097-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T11:33:11Z","timestamp":1647343991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-07097-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["7097"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-07097-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"19 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}